Literature DB >> 2809639

Epidemiological study of myasthenia gravis in the province of Ferrara, Italy.

M R Tola1, E Granieri, E Paolino, L Caniatti, R Quatrale, B Mazzanti, R D'Alessandro.   

Abstract

The only prevalence rate of myasthenia gravis (MG) so far estimated in Italy by an epidemiological study carried out in Pavia, North Italy, indicates a prevalence quite similar to that observed in other countries. The purpose of the survey was to verify the frequency of the disease in a geographically well-defined and previously surveyed community. On the basis of 39 cases, on 31 December 1987 the prevalence per million was 105.3 (102.3 if standardized for the Italian population). This is the highest prevalence figure yet found, indicating a value similar to that established in Northern Europe. According to Kurtzke this high prevalence rate reflects the high standard of the local public health service, which permitted a more intensive search for affected subjects.

Entities:  

Mesh:

Year:  1989        PMID: 2809639     DOI: 10.1007/bf00314895

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  Prevalence studies of multiple sclerosis, myasthenia gravis, and myopathies in Kumamoto district, Japan.

Authors:  S Araki; M Uchino; T Kumamoto
Journal:  Neuroepidemiology       Date:  1987       Impact factor: 3.282

Review 2.  Epidemiology of myasthenia gravis.

Authors:  J F Kurtzke
Journal:  Adv Neurol       Date:  1978

3.  Epidemiology of myasthenia gravis in Finland.

Authors:  E Hokkanen
Journal:  J Neurol Sci       Date:  1969 Nov-Dec       Impact factor: 3.181

4.  The prevalence of some neurological diseases in Iceland.

Authors:  K R Gudmundsson
Journal:  Acta Neurol Scand       Date:  1968       Impact factor: 3.209

5.  Epidemiological and prognostical aspects of myasthenia gravis in Norway.

Authors:  A Storm-Mathisen
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

6.  The frequency of multiple sclerosis in Italy: a descriptive study in Ferrara.

Authors:  E Granieri; R Tola; E Paolino; G Rosati; M Carreras; V C Monetti
Journal:  Ann Neurol       Date:  1985-01       Impact factor: 10.422

Review 7.  Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.

Authors:  K E Osserman; G Genkins
Journal:  Mt Sinai J Med       Date:  1971 Nov-Dec

8.  The prevalence of multiple sclerosis and other neurological diseases in Japan.

Authors:  S Okinaka; H H Reese; S Katsuki; K Ueki; Y Kuroiwa; S Araki; H Shiraki; L T Kurland
Journal:  Acta Neurol Scand       Date:  1966       Impact factor: 3.209

9.  Epidemiology of myasthenia gravis in Norway.

Authors:  A Storm-Mathisen
Journal:  Acta Neurol Scand       Date:  1984-10       Impact factor: 3.209

10.  Myasthenia gravis; a personal study of 60 cases.

Authors:  H GARLAND; A N CLARK
Journal:  Br Med J       Date:  1956-06-02
View more
  5 in total

1.  Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

Authors:  N Sommer; B Sigg; A Melms; M Weller; K Schepelmann; V Herzau; J Dichgans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

Review 2.  Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.

Authors:  N Sommer; A Melms; M Weller; J Dichgans
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

3.  Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy.

Authors:  D Guidetti; R Sabadini; M Bondavalli; S Cavalletti; M Lodesani; R Mantegazza; V Cosi; F Solime
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

4.  Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.

Authors:  Nader Salari; Behnaz Fatahi; Yalda Bartina; Mohsen Kazeminia; Reza Fatahian; Payam Mohammadi; Shamarina Shohaimi; Masoud Mohammadi
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

5.  Incidence of thymoma in myasthenia gravis: a systematic review.

Authors:  Zhi-Feng Mao; Xue-An Mo; Chao Qin; Yong-Rong Lai; Maree L Hackett
Journal:  J Clin Neurol       Date:  2012-09-27       Impact factor: 3.077

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.